U.S. markets closed
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • Dow 30

    34,584.88
    -166.44 (-0.48%)
     
  • Nasdaq

    15,043.97
    -137.96 (-0.91%)
     
  • Russell 2000

    2,236.87
    +3.96 (+0.18%)
     
  • Crude Oil

    71.96
    -0.65 (-0.90%)
     
  • Gold

    1,753.90
    -2.80 (-0.16%)
     
  • Silver

    22.42
    -0.33 (-1.44%)
     
  • EUR/USD

    1.1732
    -0.0040 (-0.34%)
     
  • 10-Yr Bond

    1.3700
    +0.0390 (+2.93%)
     
  • GBP/USD

    1.3737
    -0.0059 (-0.43%)
     
  • USD/JPY

    109.8950
    +0.1770 (+0.16%)
     
  • BTC-USD

    48,745.00
    +866.28 (+1.81%)
     
  • CMC Crypto 200

    1,193.48
    -32.05 (-2.62%)
     
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • Nikkei 225

    30,500.05
    +176.71 (+0.58%)
     

Fifth Third (FITB) Inks Deal to Acquire Fintech Company Provide

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Fifth Third Bancorp FITB has inked a definitive agreement to acquire Provide, a fintech company that specializes in handling lending and banking for healthcare providers. The buyout will expand its national digital capabilities.

The acquisition advances Fifth Third’s efforts in the digital innovation front and expands its focus on the healthcare sector by providing a digital platform for healthcare practices, and catering to the lending and banking needs of retail healthcare providers.

The acquisition is subject to customary closing norms, including regulatory approvals, and is expected to close by early August 2021.

Markedly, the bank has been an early investor in Provide since 2018, and started funding loans through Provide’s platform in 2020. Provide has originated more than $1 billion in commercial loans since 2016, while its collaboration with Fifth Third has provided core banking and payment services to numerous clients.

Presently, Fifth Third holds nearly $400 million of Provide’s loans but will retain all of its new originations. Also, Provide will retain its brand name and continue to operate as a separate business line.

The transaction is a strategic fit as it will enable Fifth Third to offer new clients its range of banking solutions and will facilitate it to capture growth opportunities. Moreover, it offers scope to diversify and increase fee revenues. In fact, the deal is expected to generate $6 million in revenues and $14 million of expenses in the ongoing year.

Since the healthcare industry is one of the fastest-growing segments of the U.S. economy, the move is likely to be beneficial for the company. Given the tremendous scope for growth, a number of other banks are venturing into the healthcare sector and cementing their presence.

In fact, in March, KeyCorp KEY unveiled a national digital bank for healthcare professionals. Bank of America BAC has also invested in payment processing services focused on healthcare providers.

Currently, Fifth Third carries a Zacks Rank #3 (Hold). The stock has gained 36.9% over the past six months, outperforming the industry’s rally of 24.8%.

Zacks Investment Research
Zacks Investment Research

Image Source: Zacks Investment Research

A better-ranked stock in the banking space is Webster Financial Corporation WBS. The Zacks Consensus Estimate for its 2021 earnings has been unchanged over the past 30 days at $3.73. Also, it sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Bank of America Corporation (BAC) : Free Stock Analysis Report

Fifth Third Bancorp (FITB) : Free Stock Analysis Report

KeyCorp (KEY) : Free Stock Analysis Report

Webster Financial Corporation (WBS) : Free Stock Analysis Report

To read this article on Zacks.com click here.